Evaluation of the Response of Radiotherapy to Squamous Cell Carcinoma of the Head and Neck using |
Lee Sang-Wook
(Departments of Radiation Oncology, Asan Medical Center, College of Medicine, University of Ulsan)
Ryu Jin-Sook (Departments of Neclear Medicine, Asan Medical Center, College of Medicine, University of Ulsan) Yi Byong-Yong (Departments of Radiation Oncology, Asan Medical Center, College of Medicine, University of Ulsan) Kim Jong-Hoon (Departments of Radiation Oncology, Asan Medical Center, College of Medicine, University of Ulsan) Ahn Seung-Do (Departments of Radiation Oncology, Asan Medical Center, College of Medicine, University of Ulsan) Shin Seong-Soo (Departments of Radiation Oncology, Asan Medical Center, College of Medicine, University of Ulsan) Kim Sang-Yoon (Departments of Otorhinolaryngolog, Asan Medical Center, College of Medicine, University of Ulsan) Nam Soon-Yuhl (Departments of Otorhinolaryngolog, Asan Medical Center, College of Medicine, University of Ulsan) Song Si-Yeol (Departments of Radiation Oncology, Asan Medical Center, College of Medicine, University of Ulsan) Yoon Sang-Min (Departments of Radiation Oncology, Asan Medical Center, College of Medicine, University of Ulsan) Park Jin-Hong (Departments of Radiation Oncology, Asan Medical Center, College of Medicine, University of Ulsan) Kim Sung-Bae (Departments of Internal Medicine, Asan Medical Center, College of Medicine, University of Ulsan) Kim Jae-Seung (Departments of Neclear Medicine, Asan Medical Center, College of Medicine, University of Ulsan) |
1 | Kitagawa Y, Sadato N, Azurna H, et al : FDG PET to evaluate combined intra-arterial chemotherapy and radiotherapy of head and neck neoplasms. J Nucl Med. 1999 ;40 : 1132-1137 PUBMED |
2 | Lowe VJ, Dunphy FR, Varvares M, et al : Evaluation of chemotherapy response in patients with advanced head and neck cancer using [F-18]fluorodeoxyglucose positron emission tomography. Head Neck. 1997;19:666-674. DOI ScienceOn |
3 | Romer W, Hanauske A-R, Ziegler S, et al : Positron emission tomography in non-Hodgkin's lymphoma: assessment of chemotherapy with fluorodeoxyglucose. Blood. 1998 ; 91 : 4464-4471 PUBMED |
4 | Lapela M, Grenman R, Kurki T, et al : Head and neck cancer : detection of recurrence with PET and 2[F-18]fluoro-2-dexoy-D-glucose. Radiology. 1995 ; 197 : 205-211 |
5 | Greven KM, Williams DW 3rd, Keyes JW Jr, et al : Distinguishing tumor recurrence from irradiation sequelae with positron emission tomography in patients treated for larynx cancer. Int J Radiat Oncol. 1994 ; 29 : 841-845 DOI ScienceOn |
6 | Brock C, Young H, O'Reilly S, et al : Early evaluation of tumor metabolic response using 18 F-fluorodeoxyglucose and positron emission tomography : a pilot study after the phase 11 chemotherapy schedule for temozolamide in recurrent high grade gliomas. Br J Cancer. 2000 ; 82 : 608-615 DOI ScienceOn |
7 | Eichhorn T, Schroeder HG, Glanz H, Schwerk WB : Histologically controlled comparison of palpation and sonography in the diagnosis of cervical lymph node metastases. Laryngol Rhinol Otol. 1987 ; 66 : 266-274 DOI |
8 | Schelling M, Avril N, Nahrig W, et al : Positron emission tomography using 18F Fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer. J Cin Oncol. 2000 ; 18 : 1689-1695 |
9 | Fischbein NJ, Assar OS, Caputo GR, et al : Clinical utility of positron emission tomography with 18F-fluorodeoxyglucose in detecting residual/recurrent squamous cell carcinoma of the head and neck. Am J Neuroradiol. 1998 ; 19 : 1189-1196 |
10 | Haberkorn D, Strauss LG, Dimitrakopoulou A, et al : Fluoro-deoxyglucose imaging of advanced head and neck cancer after chemotherapy. J Nucl Med. 1993 ; 34 : 12-17 |
11 | Brun E, Kjellen E, Tennvall J, et al : FDG PET studies during treatment: Prediction of therapy outcome in head and neck squamous cell carcinoma. Head Neck. 2002 : 24 (2) : 127-135 |
12 | Kunkel M, Forster GJ, Reichert TE, et al : Radiation response non-invasively imaged by [18F]FDG-PET predicts local tumor control and survival in advanced oral squamous cell carcinoma. Oral Oncology. 2003 ; 39 : 170-177 DOI ScienceOn |
13 | Nuutinen J, Jyrkkio S, Lehikoinen P, Lindholm P, Minn H : Evaluation of early response to radiotherapy in head and neck cancer measured with [11-C] methionine-positron emission tomography. Radiother Oncol. 1999 ; 52 : 225-232 DOI ScienceOn |
14 | Adams S, Baum RP, Stuckensen T, Bitter K, Hor G : Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer. Eur J Nucl Med. 1998 ; 25 : 1255-1260 DOI ScienceOn |
15 | Haberkorn D, Strauss LG, Reisser C, et al : Glucose uptake, perfusion, and cell proliferation in head and neck tumors : relation of positron emission tomography to flow cytometry. J Nucl Med. 1991 ; 32 : 1548-1555 |
16 | Janson T, Westlin JE, Ahlstrom H, Lilja A, Langstrom B, Bergh J : Positron emission tomography studies in patients with locally advanced and/or metastatic breast cancer : A method for early therapy evaluation? J Clin Oncol. 1995 ;13 : 1470-1477 |
17 | Kao CH, ChangLai SP, Chieng PD, Yen RF, Yen TC : Detection of recurrent or persistent nasopharyngeal carcinomas after radiotherapy with 18-fluoro-2-deoxyglucose positron emission tomography and comparison with computed tomography. J Clin Oncol. 1998 ; 16 : 3550-3555 DOI PUBMED |
18 | Schulte M, Brecht Krauss D, Werner M, et al : Evaluation of neoadjuvant therapy response of osteogenic sarcoma using FDG-PET. J Nucl Med. 1999 ; 40 : 1637-1643 PUBMED |
19 | Laubenbacher C, Saumweber D, Wagner-Manslau C, et al : Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous-cell carcinomas. J Nucl Med. 1995 ; 36 : 1747-1757 PUBMED |
20 | Mitsuhashi N, Hayakawa K, Hasegawa M, et al : Clinical FDGPET in diagnosis and evaluation of radiation response of patients with nasopharyngeal tumor. Anticancer Res. 1998 ;18 : 2827-2832 PUBMED |
21 | Greven KM, Williams DW 3rd, Keyes JW Jr, et al : Positron emission tomography of patients with head and neck carcinoma before and after high dose irradiation. Cancer. 1994 ; 74 : 1355-1359 DOI ScienceOn |